Ayşe Özaydın | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Prof. Ayşe Özaydın | Medicine and Dentistry | Best Researcher Award

Prof. Dr. (MD, MPH, PhD) at MarmaraÜniversitesi, Turkey

Prof. Dr. Ayşe Nilüfer (Gülersoy) Özaydın is a distinguished academic and public health expert with a career spanning over four decades. Born in Eskişehir, Turkey in 1959, she has contributed extensively to the fields of epidemiology, cancer prevention, reproductive health, and health education. She currently serves as a Professor in the Department of Public Health at Marmara University School of Medicine, Istanbul. Her vast experience includes roles as a guest lecturer at several medical schools, both in Turkey and Cyprus, and she has held key leadership positions in national health organizations and academic committees. Prof. Özaydın is a recognized figure in public health circles for her advocacy and pioneering work in breast cancer awareness and prevention. With numerous national and international affiliations, including WHO and GFMER, she has established herself as a thought leader and changemaker. Her work bridges clinical research, health policy, and education, impacting both public health systems and academic communities.

Professional Profile

Education

Prof. Dr. Özaydın’s academic journey began with a medical degree from Hacettepe University in 1984, followed by a master’s and Ph.D. in Public Health at the same institution. She further enhanced her expertise with postgraduate studies in Epidemiology and Statistics at the Liverpool School of Tropical Medicine in the UK. Over the years, she pursued a wide array of certifications in areas such as health education, reproductive health, clinical research methods, occupational health, and medical education, reflecting her commitment to lifelong learning and multidisciplinary expertise. She has completed advanced training courses at globally recognized institutions including Johns Hopkins University and the University of Maastricht. Her education is not only marked by academic degrees but by continuous professional development, particularly in emerging areas like cancer bioinformatics and qualitative research methods. This robust educational foundation has been critical in shaping her holistic and proactive approach to public health challenges in both academic and policy-making settings.

Professional Experience

Prof. Dr. Özaydın has accumulated extensive professional experience across clinical, academic, and governmental health sectors since beginning her career in 1984. She has worked as a physician in various public health centers across Turkey, assuming critical roles in immunization campaigns and women’s health services. Transitioning into academia, she joined Marmara University’s School of Medicine, where she advanced from lecturer to full professor in the Department of Public Health. Alongside her academic roles, she has served as a guest faculty member at institutions like Eastern Mediterranean University, Near East University, and Okan University. Her leadership includes appointments to advisory boards of the Turkish Ministry of Health, WHO initiatives, and national health strategy groups. In addition, she has held presidencies at key organizations such as the Breast Health Society (MEMEDER) and the Marmara Health Education and Research Foundation (MARSEV). Her professional record reflects deep engagement in both health system strengthening and medical education innovation.

Research Interest

Prof. Özaydın’s research interests are rooted in public health and focus extensively on breast cancer prevention, screening practices, and public awareness strategies. She is also deeply engaged in studies surrounding sexual and reproductive health, family planning, sexually transmitted infections, immunization programs, and occupational diseases. Her interdisciplinary approach merges clinical epidemiology with health education and behavior change communication. She has led and contributed to prevalence surveys, curriculum development projects, and national screening programs. Recently, she has explored newer research avenues like cancer bioinformatics and health-related social determinants in medical students. Her work is characterized by its direct impact on public health policy and community health improvement, with a particular emphasis on underserved populations. Prof. Özaydın’s research not only informs academic literature but also translates into practical guidelines and strategic plans for health ministries and global health bodies. Her studies are frequently published in peer-reviewed journals and presented at major international conferences.

Awards and Honors

Throughout her illustrious career, Prof. Özaydın has received numerous honors and appointments recognizing her academic and professional contributions. She is a valued member of the WHO Global Breast Cancer Initiative and has been invited to serve on scientific and advisory boards for Turkey’s Ministry of Health, including strategic task forces on cancer epidemiology and reproductive health. She was appointed president of MEMEDER and MARSEV, reflecting her leadership in health advocacy and education. Her contributions have been instrumental in developing national strategies for HIV/AIDS, family planning, and cancer screening. She has represented Turkey in multiple international collaborations and training programs, and her coordination role for the Geneva Foundation for Medical Education and Research highlights her global influence. Though specific award titles are not listed, her numerous appointments, leadership roles, and committee memberships across prestigious health and academic institutions serve as strong testaments to her recognition and esteem in the medical and scientific community.

Conclusion

Dr. Özaydın is a highly accomplished researcher with a distinguished career in public health, medical education, and epidemiology. Her expertise in areas like breast cancer prevention and reproductive health, along with her international collaborations and publications, positions her as a strong candidate for the Best Researcher Award. With a focus on expanding her interdisciplinary efforts and enhancing the global reach of her research, Dr. Özaydın’s contributions could be even more impactful in the future.

Publications Top Notes

  • Prevalence and risk factors of Helicobacter pylori in Turkey
    ➤ Authors: N. Özaydın, S.A. Turkyilmaz, S. Cali
    ➤ Citations: 264

  • Erkeklerde Cinsel Mitlere İnanma Oranları ve Mitlere İnanmayı Etkileyen Faktörler
    ➤Authors: F. Torun, S.D. Torun, A.N. Özaydın
    ➤ Citations: 127

  • Effect of extremely low frequency electromagnetic fields on growth rate and morphology of bacteria
    ➤ Authors: A. Inhan-Garip, B. Aksu, Z. Akan, D. Akakin, A.N. Özaydın, T. San
    ➤ Citations: 120

  • Assessment of sociodemographic and economic factors affecting immunization services in Istanbul
    ➤ Authors: H.H. Topuzoglu, A. Özaydın, G.A. Cali, D. Cebeci, S. Kalaca
    ➤ Citations: 102

  • Bahçeşehir’de oturan kadınların meme kanseri bilgi düzeyleri ve uygulamaları
    ➤ Authors: A.N. Özaydın, B.M. Güllüoğlu, P.C. Ünalan, S. Gorpe, B.R. Öner, et al.
    ➤ Citations: 71

  • Survey on a mammographic screening program in Istanbul
    ➤ Authors: V. Özmen, A.N. Özaydın, N. Cabioglu, B.M. Gulluoglu, P.C. Unalan, et al.
    ➤ Citations: 59

  • Türkiye’de evli erkeklerin aile planlaması yöntemlerini kullanmalarını etkileyen faktörler
    ➤Authors: L. Akın, N. Özaydın, D. Aslan
    ➤ Citations: 57

  • Sources of breast cancer knowledge and screening attendance – Moda, Istanbul
    ➤ Authors: A. Yildirim, A. Özaydın
    ➤ Citations: 50

  • Isotretinoin has no negative effect on attention, executive function and mood
    ➤ Authors: T. Ergun, D. Seckin, N. Özaydın, Ö. Bakar, A. Comert, et al.
    ➤ Citations: 47

  • Meme Kanserinde Tarama ve Tanı (İstanbul Konsensus Konferansı)
    ➤ Authors: S. Baskan, K. Atahan, E. Arıbal, N. Özaydın, P. Balcı, E. Yavuz
    ➤ Citations: 44

  • Cost-effectiveness of breast cancer screening in Turkey
    ➤ Authors: V. Özmen, S.Ö. Gürdal, N. Cabioğlu, B. Özcinar, A.N. Özaydın, et al.
    ➤ Citations: 38

  • Successful first round results of a Turkish breast cancer screening program
    ➤ Authors: A. Kayhan, S.Ö. Gürdal, N. Özaydın, N. Cabioglu, E. Ozturk, et al.
    ➤ Citations: 34

  • Diagnostic performance of AI for cancers in a mammography screening program
    ➤ Authors: I. Kizildag Yirgin, Y.O. Koyluoglu, M.E. Seker, S. Ozkan Gurdal, A.N. Özaydın, et al.
    ➤ Citations: 26

  • Dijital yerlilerin gözünden dijital okuryazarlık
    ➤ Authors: A. Özaydın, O. Kumral
    ➤ Citations: 23

  • The relationship between males’ attitudes to partner violence and contraception
    ➤ Authors: L. Akin, N. Özaydın
    ➤ Citations: 23

  • Kadın ve şiddet
    ➤ Authors: N. Özaydın, O. Üner, A. Akın
    ➤ Citations: 23

  • Bahçeşehir Meme Kanseri Tarama Projesi İlk Dönem Sonuçları
    ➤ Authors: A. Kayhan, S.Ö. Gürdal, N. Özaydın, E. Öztürk, N. Cabıoğlu, E. Arıbal
    ➤ Citations: 20

  • Care burden among informal caregivers of ALS patients
    ➤ Authors: Z. Tülek, A. Özakgül, N. Alankaya, A. Dik, A. Kaya, P.C. Ünalan, A.N. Özaydın, et al.
    ➤ Citations: 16

  • İstanbul/Moda’da kadınların meme kanseri bilgisi ve tarama katılımı
    ➤ Authors: A. Demir Yıldırım, A. Nilüfer Özaydın
    ➤ Citations: 16

  • İstenmeyen gebelikler ve düşüklerin kadın sağlığına etkileri
    ➤ Authors:  N. Özaydın, A. Akın
    ➤ Citations: 15

 

Alexander Kirichenko | Health Professions | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. Alexander Kirichenko | Health Professions | Best Researcher Award

Professor Drexel University College of Medicine Drexellat at Allegheny General Hospital, United States

Dr. Alexander V. Kirichenko, MD, PhD, is a distinguished radiation oncologist and researcher with extensive expertise in stereotactic body radiotherapy (SBRT) and radiation biology. He currently serves as an Attending Radiation Oncologist at Allegheny General Hospital and System Director for Stereotactic Body Radiotherapy & Gastrointestinal Cancers Program at Allegheny Health Network Cancer Institute. With a career spanning over four decades, Dr. Kirichenko has made significant contributions to oncology research, particularly in hepatocellular carcinoma and functional treatment planning. His humanitarian efforts include leading international collaborations to advance radiation oncology care in Ukraine. A dedicated educator and innovator, Dr. Kirichenko has contributed to multiple clinical trials, patents, and book chapters, shaping the future of radiation oncology.

Professional Profile

Education

Dr. Kirichenko earned his MD from Kyiv Medical University, Ukraine, in 1981, followed by a residency in Radiation Oncology and Nuclear Medicine. He later obtained a PhD in Radiation Biology and a D.Sc. in Radiation Medicine. In pursuit of advanced training, he completed a postdoctoral fellowship at MD Anderson Cancer Center and obtained U.S. medical licensure from the University of Virginia. His residency training in General Surgery and Radiation Oncology at the University of Virginia further solidified his expertise. These rigorous academic and clinical experiences have enabled him to excel in both patient care and research.

Professional Experience

With a career dedicated to radiation oncology, Dr. Kirichenko has held various prestigious academic and clinical positions. He served as an Associate Professor at the Ukrainian National Cancer Institute and the University of Virginia before joining Allegheny General Hospital in 2006. As a leading expert, he has been involved in the development of advanced radiation therapies, including SBRT for liver malignancies. His work also extends to international collaborations, where he has played a pivotal role in enhancing global cancer care standards. His leadership within multiple healthcare institutions has made a lasting impact on cancer treatment methodologies.

Research Interests

Dr. Kirichenko’s research primarily focuses on radiation-induced toxicity, functional treatment planning, and advanced imaging techniques in radiation therapy. His studies on SBRT for hepatocellular carcinoma have contributed to improving survival outcomes while minimizing toxicity. He has also explored the use of superparamagnetic iron oxide nanoparticles (SPION) for enhancing MRI-guided radiotherapy. Through his involvement in numerous clinical trials and NIH-funded studies, he has pioneered innovative approaches in liver and rectal cancer treatment. His research continues to influence clinical practices, bridging the gap between experimental oncology and patient-centered care.

Awards and Honors

Throughout his career, Dr. Kirichenko has received numerous accolades for his contributions to radiation oncology. He has been recognized as one of the Best Doctors in America (2013–2023) and has received the Health Care Heroes Award from Pittsburgh Business Times. His leadership in national and international oncology projects has earned him appointments to expert panels, including the National Center for Biosecurity and Biodefense Preparedness. His extensive list of invited lectures, patents, and book chapters further reflects his commitment to advancing cancer research and treatment.

Conclusion

Dr. Alexander V. Kirichenko is a highly qualified and impactful researcher in radiation oncology with strong contributions to clinical innovation, translational research, and international collaboration. His extensive body of work, patents, leadership roles, and humanitarian contributions make him a strong candidate for the Best Researcher Award. If supplemented with further high-impact publications, mentorship initiatives, and policy engagements, his profile would be nearly unbeatable.

Publications Top Notes

  • Title: Chronomodulated chemotherapy and irradiation: An idea whose time has come?

  • Authors:

    • Tyvin A. Rich

    • Charles H. Shelton III

    • Alexander V. Kirichenko

    • Martin Straume

  • Journal: Chronobiology International

  • Year of Publication: 2002

  • Citations: 18 (as per available sources)

 

Subash-Babu Pandurangan | Molecular nutrition | Best Researcher Award

Posted on by ScienceFather

Dr. Subash-Babu Pandurangan | Molecular nutrition | Best Researcher Award

Professor , KING SAUD UNIVERSITY,Saudi Arabia

Dr. P. Subash Babu is an Associate Professor in Biochemistry at the Department of Food Science and Nutrition, King Saud University, Riyadh, KSA. With expertise in molecular biology, nutrition, and metabolic disorders, he specializes in adipogenesis, immunobiology, obesity, diabetes, cardiovascular diseases, and cancer. He has a strong background in working with human mesenchymal stem cells (MSCs) and miRNA profiling to explore gene-nutrient interactions in disease pathogenesis. Dr. Babu has extensive teaching experience and has served as a visiting professor and adjunct faculty at multiple international institutions. He has published extensively in top-tier journals and has contributed significantly to advancing our understanding of cellular biology in disease mechanisms. He has also worked on various industrial and clinical research projects, bridging the gap between academia and real-world health applications.

Profile

Strengths for the Award

  1. Diverse Research Portfolio: Dr. Subash Babu has an extensive and varied research portfolio, covering key areas in biochemistry, molecular nutrition, and immunobiology. His work spans across metabolic disorders like obesity, diabetes, and cardiovascular diseases (CVD), as well as cancer research, focusing on the molecular mechanisms and cellular processes underpinning these conditions. His interdisciplinary approach, combining molecular biology with clinical applications, strengthens his profile for the Best Researcher Award.
  2. Innovative and Cutting-Edge Research: His current research on molecular diagnostics, adipogenesis, and miRNA profiling reflects cutting-edge approaches in the study of human metabolism and disease pathogenesis. The investigation of foodborne carcinogens in cancer development and his work with Mesenchymal Stem Cells (MSCs) to understand adipocyte differentiation represent innovative contributions to both basic and applied biochemistry.
  3. Collaborations and International Impact: Dr. Subash Babu’s collaborations with multiple research institutions and universities, both in Saudi Arabia and internationally (such as the University of Reading, UK), as well as his role as a visiting professor, underscore his global scientific influence. His work is not only recognized within his own institution but also internationally, highlighting his contributions to advancing scientific knowledge and fostering international academic partnerships.
  4. Publications and Editorial Involvement: His extensive publication record, with numerous articles in peer-reviewed journals like BMC Nutrition, Molecules, and Nanomaterials, showcases his consistent contribution to the field. His role on the editorial boards of several prestigious international journals further underscores his leadership in the scientific community.
  5. Research Translation and Clinical Relevance: Dr. Subash Babu’s research goes beyond the lab, with applications in clinical biochemistry, toxicology, pharmacology, and drug development. His work on the pharmacological properties of food components, such as those from pistachio seed coat and Lepidium sativum, exemplifies his ability to translate scientific findings into practical solutions for health and disease prevention.
  6. Awards and Recognitions: The Senior Research Fellowship awarded by the Indian Council of Medical Research (ICMR) is a testament to his recognition as an emerging researcher in the early stages of his career. This, coupled with the granted patent for a novel antidiabetic compound derived from Nymphaea stellata, demonstrates his innovation and ability to push the boundaries of research.

Areas for Improvement

  1. Interdisciplinary Integration: While Dr. Subash Babu’s research is already highly interdisciplinary, further integration with cutting-edge technologies such as AI/ML for data analysis in biomedical research or precision medicine could further strengthen the translational potential of his work. Utilizing such technologies could also improve the predictive power of his research models, especially in areas like miRNA profiling.
  2. Broader Outreach and Public Engagement: Increasing the outreach of his research findings to a broader public audience, particularly in the context of health and nutrition education, would enhance the impact of his work. Although his publications are well-regarded in scientific circles, greater visibility among non-specialists could lead to greater societal benefits, especially in addressing global health challenges like obesity, diabetes, and cancer.
  3. Collaborations with Industry: Although Dr. Subash Babu has worked in food production and nutrition assessment, further strengthening collaborations with the pharmaceutical industry or biotechnological companies could open up more avenues for commercialization of his findings, especially in drug development and diagnostic tools for metabolic disorders and cancers.
  4. Focus on Longitudinal Studies: Incorporating more longitudinal or population-based studies into his research could provide further validation of the biochemical and molecular mechanisms observed in in vitro and in vivo models, leading to more robust clinical insights and applications.

Education 

Dr. P. Subash Babu holds a Ph.D. in Biochemistry (2004–2009) from the University of Madras, India, specializing in Clinical Biochemistry. He completed his M.Phil. in Biochemistry (2002–2004) at Annamalai University and earned his M.Sc. in Biochemistry (2000–2002) from the same institution. His academic journey began with a B.Sc. in Biochemistry (1997–2000). During his doctoral research, he focused on clinical biochemistry, which laid the foundation for his later research interests in molecular diagnostics, obesity, diabetes, cardiovascular diseases, and cancer biology. Dr. Babu’s education and research training were further enhanced by his postdoctoral experience in adipogenesis, immunomodulation, and miRNA profiling at King Saud University, where he currently serves as an Associate Professor. His academic credentials reflect a strong commitment to both the theoretical and applied aspects of biochemistry and molecular biology in health and disease.

Experience 

Dr. P. Subash Babu has more than 14 years of academic and research experience. He has been an Associate Professor in Biochemistry at the Department of Food Science and Nutrition, King Saud University, Riyadh, KSA, since 2010, where he teaches postgraduate courses in biochemistry, nutrition, metabolism, and clinical biochemistry. Prior to this, he worked as a Lecturer in the Department of Biotechnology at Loyola College, University of Madras, India, from 2007 to 2009. Dr. Babu has also served as a visiting professor at several institutions, including the University of Reading, UK, and M.S. Ramaiah University of Applied Sciences, India. His research focus spans areas like adipogenesis, diabetes, immunomodulation, and cancer biology, with a particular emphasis on molecular diagnostics. Additionally, he has worked as a project manager in diabetes research and as a consultant in food and nutrition assessment in industry, bridging academic research with real-world applications.

Awards and Honors

Dr. P. Subash Babu has been recognized for his outstanding research contributions. He was awarded the Senior Research Fellowship by the Indian Council of Medical Research (ICMR) from February 2006 to January 2008, a testament to his early commitment to scientific excellence. He also holds a patent for a novel compound, Nymphayol, with antidiabetic properties, developed in collaboration with S. Ignacimuthu in 2007. Dr. Babu’s research has been extensively published in leading scientific journals, showcasing his expertise in biochemistry, molecular biology, and clinical nutrition. His editorial roles in multiple international journals reflect his standing in the global scientific community. His contributions to research in metabolic disorders, adipogenesis, and cancer biology have earned him recognition among peers, and he continues to be an active participant in research and innovation in these areas. Dr. Babu’s work in the field of nutritional molecular biology remains pivotal in understanding chronic diseases.

Research Focus

Dr. P. Subash Babu’s research primarily focuses on the molecular mechanisms underlying nutrition and metabolic disorders. His studies on adipogenesis, immunobiology, obesity, and diabetes delve into the role of nutrients and gene interactions in human mesenchymal stem cells (MSCs), specifically their differentiation into adipocytes. He investigates the impact of dietary components on cell signaling, gene expression, and miRNA regulation related to metabolic disorders and cardiovascular diseases (CVD). His research also includes the role of foodborne carcinogens in cancer development through in vitro and in vivo models. Dr. Babu has a special interest in how microRNAs regulate cell death (apoptosis and necrosis), survival, and differentiation in various diseases. His work aims to identify potential therapeutic targets for metabolic disorders and cancer, bridging molecular biology, clinical nutrition, and drug development. Dr. Babu’s research continues to explore innovative solutions for managing chronic diseases through nutrition and molecular medicine.

Publication 

  1. Impact of various dietary lipids on amelioration of biomarkers linked to metabolic syndrome in both healthy and diabetic Wistar rats 🐀🥗
  2. Hemp Seed Oil Inhibits the Adipogenicity of the Differentiation-Induced Human Mesenchymal Stem Cells through Suppressing the Cannabinoid Type 1 (CB1) 🧬🌱
  3. Neuroprotective Effect of Solid Lipid Nanoparticles Loaded with Lepidium sativum (L.) Seed Bioactive Components Enhance Bioavailability and Wnt/β-Catenin/Camk-II Signaling Cascade in SH-SY5Y Neuroblastoma Cells 🧠💊
  4. Luteolin-7-O-rutinoside Protects RIN-5F Cells from High-Glucose-Induced Toxicity, Improves Glucose Homeostasis in L6 Myotubes, and Prevents Onset of Type 2 Diabetes 🍇💉
  5. Cis-vaccinic acid, Dibutyl-Cyanamide and 9, 12-Octadecadienoic acid from pistachio (Pistachia vera) seed coat (PSCE) induced nuclear damage and cytotoxicity in human colon cancer HT-115 cells 🌰🍂
  6. Ononitol Monohydrate—A Glycoside Potentially Inhibit HT-115 Human Colorectal Cancer Cell Proliferation through COX-2/PGE-2 Inflammatory Axis Regulations 🍃🔬
  7. Antimicrobial Properties of Zinc Oxide Nanoparticles Synthesized from Lavandula pubescens Shoot Methanol Extract 🦠⚙️
  8. Cinchona officinalis Phytochemicals-Loaded Iron Oxide Nanoparticles Induce Cytotoxicity and Stimulate Apoptosis in MCF-7 Human Breast Cancer Cells 🌿🧪
  9. Ocimum basilicum L. Methanol Extract Enhances Mitochondrial Efficiency and Decreases Adipokine Levels in Maturing Adipocytes Which Regulate Macrophage Systemic Inflammation 🍃🧬
  10. Punicalagin and Ketogenic Amino Acids Loaded Organic Lipid Carriers Enhance the Bioavailability, Mitochondrial β-Oxidation, and Ketogenesis in Maturing Adipocytes 🍊🥑

Conclusion

Dr. P. Subash Babu is a highly deserving candidate for the Best Researcher Award due to his significant and sustained contributions to the fields of biochemistry, molecular nutrition, and biomedical research. His work is innovative, has high translational potential, and addresses critical health issues such as obesity, diabetes, cardiovascular diseases, and cancer. His extensive publication record, interdisciplinary research, international collaborations, and role in advancing scientific knowledge make him an exemplary figure in the research community.Given his strengths, expanding his interdisciplinary approach and outreach efforts, along with potential collaborations with the industry, could further enhance the impact and applicability of his work. Nonetheless, his accomplishments thus far already mark him as a leader in his field, and his contributions continue to benefit both the scientific community and global public health.

Olga Moskalenko | Medicine | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Olga Moskalenko | Medicine | Best Researcher Award

Candidate of Biological Sciences, Russia

Olga Leonidovna Moskalenko is a dedicated educator and researcher in the fields of pediatrics, psychology, and medical education. With extensive training in various medical and pedagogical disciplines, she has established herself as a prominent figure in her field. 🌟

Publication Profile

Scopus

Education

Olga graduated from the Krasnoyarsk State Medical Academy in 2005, specializing in Pediatrics. She has pursued multiple advanced training programs in Medical Informatics, Pedagogical Education, and Psychology, further enriching her knowledge and skills. 🎓

Experience

She currently serves as an Associate Professor at the Krasnoyarsk State Medical University, where she contributes to the Department of Histology, Cytology, and Embryology. Additionally, she holds the position of Senior Researcher at the Research Institute of Medical Problems of the North, showcasing her commitment to advancing medical research and education. 🏥

Research Interests

Olga’s research focuses on critical topics such as internet addiction in adolescents, psychological interviewing, and pathophysiology. Her work aims to address significant psychological and health issues impacting young people today. 🔬

Awards

Throughout her career, Olga has led numerous scientific projects and received grants for her research on internet addiction and cancer diagnostics, reflecting her dedication to improving health outcomes in her community. 🏆

Publications

Griffiths, M. D., & Moskalenko, O. L. (2024). Title of the Publication. Journal Name.

Moskalenko, O. L. (2021). Title of the Publication. Journal Name.

Moskalenko, O. L. (2020). Title of the Publication. Journal Name.

 

Prof. Arturo Benayas Ayuso | Inventive Award | Best Researcher Award

Posted on by ScienceFather

Prof. Arturo Benayas Ayuso | Inventive Award | Best Researcher Award

Prof. Arturo Benayas Ayuso, Universidad Politécnica de Madrid, Spain

Arturo Benayas Ayuso is a seasoned naval architect with an MSc from the Universidad Politécnica de Madrid and currently pursuing a PhD focused on IoT applications in ship design and management. He serves as the Integration Lead for the “El Cano” platform at NAVANTIA, where he drives advancements in naval shipbuilding through industry 4.0 technologies and PLM processes. With extensive experience in PLM integration and software deployment, he has held various key roles, including Technical Account Manager for FORAN-PLM integration and Associate Manager at SENER. A multilingual professional fluent in Spanish, English, French, and Portuguese, Arturo has authored several papers and contributed to conferences on shipbuilding technologies. He also lectures on statistics at Universidad Complutense de Madrid, fostering the next generation of economists and business leaders. His technical expertise spans a wide range of programming languages, CAD/CAM/CAE systems, and PLM platforms, making him a pivotal figure in the maritime engineering field.

Professional Profile:

Scopus

Summary of Suitability for Best Researcher Award: Arturo Benayas Ayuso

Arturo Benayas Ayuso’s extensive qualifications and contributions to naval architecture and digital transformation in shipbuilding position him as an exceptional candidate for the Best Researcher Award. With a Master’s degree in Naval Architecture and ongoing PhD research focusing on IoT applications in ship design and management, he demonstrates a strong academic foundation.

Education:

  • MSc in Naval Architecture
    • Institution: Universidad Politécnica de Madrid
    • Year: 2005
    • Specialization: Marine motors specialist
  • PhD in Naval Architecture (ongoing)
    • Research Focus: IoT applied to Ship Design, Shipbuilding, Manufacturing, and Ship Management

Work Experience:

  • Digitization & PLM Associate Manager
    • Company: Accenture – Tecnilógica
    • Duration: 2020 – Present
    • Key Responsibilities:
      • Integration Lead for the “El Cano” platform at NAVANTIA, overseeing the design, building, deployment, and maintenance of naval ships.
      • Advising on PLM processes and validating software capabilities, functional specifications, and technical requirements.
      • Coordinating documentation for new tenders, including economic assessments.
      • Managing a fixed team of 7 and a floating development team of up to 10, utilizing Agile methodologies.
  • FORAN-PLM Technical Account Manager
    • Company: SENER, Ingeniería y Sistemas, S.A.
    • Duration: 2019 – 2020
    • Responsibilities: Managed the integration of FORAN for the migration of the Spanish S80P submarine and oversaw new developments for Windchill PLM integration.
  • Solution Architect Associate Manager
    • Company: SENER, Ingeniería y Sistemas, S.A.
    • Duration: 2012 – 2020
    • Responsibilities: Defined tasks for FORAN-PLM integration and led development teams focused on an OOTB (Out-of-the-Box) paradigm for Windchill and Teamcenter PLM.

Publication top Notes:

Internet of Things Cybersecurity: Blockchain as First Securitisation Layer of an IoT Network

Data management for smart ship or how to reduce machine learning cost in IoS applications

Automated/controlled storage for an efficient mbom process in the shipbuilding managing the iot technology

Carolin C. Hack | Medicine and Dentistry | Best Scholar Award

Posted on by ScienceFather

Dr. Carolin C. Hack | Medicine and Dentistry | Best Scholar Award

Deputy clinical director at Erlangen University Hospital Women’s Clinic, Germany

Priv.-Doz. Dr. med. Carolin Christine Hack is an accomplished medical professional and the Deputy Director of the Women’s Clinic at the University Hospital Erlangen. With a specialization in gynecological oncology and integrative medicine, Dr. Hack combines her clinical expertise with a passion for patient-centered care. Her innovative approach to medicine, along with her extensive training and research, positions her as a leading figure in her field.

Profile

Scopus

Education 🎓

Dr. Hack completed her medical degree at Friedrich-Alexander University Erlangen-Nuremberg, where she also pursued her habilitation in “Integrative Medicine in the Treatment of Gynecological Oncology Patients.” Her academic journey included a comprehensive curriculum that laid the groundwork for her clinical and research interests, ultimately leading to a robust foundation in both conventional and integrative medicine.

Experience 💼

With over a decade of experience at the University Hospital Erlangen, Dr. Hack has advanced through various roles, from assistant physician to Deputy Director of the Women’s Clinic. She has managed quality assurance initiatives and specialized in integrative medicine, focusing on the intersection of traditional and complementary therapies in patient care. Her leadership in the clinic has fostered a collaborative environment that emphasizes innovative treatment methodologies.

Research Interests 🔍

Dr. Hack’s research primarily focuses on integrative medicine and complementary therapy methods, with a specific emphasis on mammographic density as a risk factor for breast cancer. Her work seeks to enhance patient outcomes through evidence-based practices that incorporate holistic approaches to treatment.

Awards 🏆

Dr. Hack’s contributions to gynecological oncology have been recognized with multiple awards, including:

  • 2015: Klaus-Dieter-Schulz-Versorgungsforschungspreis
  • 2016: First Science Award from the German Society for Senology
  • 2018: Award from the Foundation for Women and Child Health
  • 2022: Research Award for Complementary Medicine from NATUM e.V.

Publications 📚

Dr. Hack has an extensive publication record, including:

  • The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype
    • Authors: Ziegler, P., Hartkopf, A.D., Wallwiener, M., Schneeweiss, A., Goossens, C.
    • Journal: BMC Cancer
    • Year: 2024
    • Volume: 24(1), Article 1284
  • Tumor-Associated Neutrophils Are a Negative Prognostic Factor in Early Luminal Breast Cancers Lacking Immunosuppressive Macrophage Recruitment
    • Authors: Schmidt, E., Distel, L., Erber, R., Fietkau, R., Schnellhardt, S.
    • Journal: Cancers
    • Year: 2024
    • Volume: 16(18), Article 3160
  • Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole
    • Authors: Fasching, P.A., Hack, C.C., Nabieva, N., Fehm, T.N., Häberle, L.
    • Journal: European Journal of Cancer
    • Year: 2024
    • Volume: 209, Article 114239
  • Correlation of RANK and RANKL with mammographic density in primary breast cancer patients
    • Authors: Wunderle, M., Heindl, F., Behrens, A.S., Fasching, P.A., Emons, J.
    • Journal: Archives of Gynecology and Obstetrics
    • Year: 2024
    • Volume: 310(2), pp. 1223–1233
  • CDK4/6 Inhibition – Therapy Sequences and the Quest to Find the Best Biomarkers – An Overview of Current Programs
    • Authors: Schneeweiss, A., Brucker, S.Y., Huebner, H., Fehm, T.N., Fasching, P.A.
    • Journal: Geburtshilfe und Frauenheilkunde
    • Year: 2024
    • Volume: 84(5), pp. 443–458
  • Initial experience with a next-generation low-field MRI scanner: Potential for breast imaging?
    • Authors: Dietzel, M., Laun, F.B., Heiß, R., Uder, M., Ohlmeyer, S.
    • Journal: European Journal of Radiology
    • Year: 2024
    • Volume: 173, Article 111352
  • Unbiased high-dimensional flow cytometry identified NK and DC immune cell signature in Luminal A-type and triple negative breast cancer
    • Authors: Heger, L., Heidkamp, G.F., Amon, L., Beckmann, M.W., Dudziak, D.
    • Journal: OncoImmunology
    • Year: 2024
    • Volume: 13(1), Article 2296713
  • Predicting mammographic density with linear ultrasound transducers
    • Authors: Behrens, A., Fasching, P.A., Schwenke, E., Beckmann, M.W., Emons, J.
    • Journal: European Journal of Medical Research
    • Year: 2023
    • Volume: 28(1), Article 384
  • Evaluation of automated techniques for extraction of circulating cell-free DNA for implementation in standardized high-throughput workflows
    • Authors: Lehle, S., Emons, J., Hack, C.C., Ruebner, M., Huebner, H.
    • Journal: Scientific Reports
    • Year: 2023
    • Volume: 13(1), Article 373
  • Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care – The PreFace Study
    • Authors: Hack, C.C., Maass, N., Aktas, B., Hein, A., Fasching, P.A.
    • Journal: Geburtshilfe und Frauenheilkunde
    • Year: 2023
    • Volume: 84(2), pp. 185–195

Conclusion ✨

Priv.-Doz. Dr. med. Carolin Christine Hack is an exemplary candidate for the Best Researcher Award. Her innovative contributions to integrative medicine and gynecological oncology, coupled with her extensive publication record and commitment to patient care, position her as a leader in her field. By addressing areas for improvement, such as interdisciplinary collaboration and public engagement, Dr. Hack can further enhance her impact in research and continue to advance the frontiers of medical knowledge.

Shahab Reaeian | Prevention | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Shahab Reaeian | Prevention | Best Researcher Award

Academic member, Kermanshah University of Medical Sciences, Iran

Dr. Shahab Rezaeian is an esteemed epidemiologist from Iran, specializing in public health and epidemiology. With a PhD from Shiraz University of Medical Sciences, he has dedicated his career to understanding the dynamics of diseases and their impact on communities. He is currently a faculty member at Kermanshah University of Medical Sciences, contributing to the field through both research and education. 🩺📚

Publication Profile

Google scholar

Education

Dr. Rezaeian earned his B.S. in Public Health from Iran University of Medical Sciences in 2007, followed by an MSc in Epidemiology from Hamadan University of Medical Sciences in 2012. He completed his PhD in Epidemiology at Shiraz University of Medical Sciences in 2016, focusing his research on the survival trends and blood demand of beta-thalassemia patients. 🎓

Experience

Dr. Rezaeian has extensive experience in epidemiological research, particularly in assessing the risk factors for various health conditions, including congenital hypothyroidism and HIV. His professional journey reflects a commitment to advancing public health through rigorous data analysis and interpretation. 💼

Research Focus

His primary research interests include epidemiological modeling, public health interventions, and the study of congenital conditions. Dr. Rezaeian aims to contribute to effective health policies and practices by analyzing health data and identifying key determinants of health outcomes. 🔬📈

Awards and Honours

Dr. Rezaeian has received several accolades for his contributions to epidemiology and public health, including recognition for his impactful research publications and involvement in various health initiatives. His work continues to inspire future generations of health professionals. 🏆

Publication Top Notes

Dr. Rezaeian has authored numerous significant publications in reputable journals, contributing to the scientific community’s understanding of epidemiology and public health. Some notable works include:

Influenza A (H1N1) in Hamedan Province, Western Iran in 2009: A Case-Control Study (2010, J Res Health Sci) – Cited by 30

Quality of Cohort Studies Reporting Post the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement (2011, Epidemiology and Health) – Cited by 50

The Quality of the Reporting of Randomized Controlled Trials after CONSORT Statement in the Prestigious Journals (2013, Shiraz E Medical Journal) – Cited by 40

Difference in the Incidence of Congenital Hypothyroidism Among World Countries (2013, Ann Saudi Med) – Cited by 20

Social Determinants of Health Associated with Self-Reported HIV Testing Among Women (2013, Iran J Public Health) – Cited by 35

Risk Factors of Congenital Hypothyroidism Using Propensity Score: A Matched Case-Control Study (2013, J Res Health Sci) – Cited by 25

Salma Younes | Biomedical Sciences | Best Researcher Award

Posted on by ScienceFather

Ms. Salma Younes | Biomedical Sciences | Best Researcher Award

Salma Younes, Qatar University, Qatar

Profile

Google Scholar

Short Bio 🌟

Salma Younes, MSc, MLS (ASCP)CM, is a dedicated and accomplished Ph.D. candidate in Biomedical Science at Qatar University. With an impressive portfolio of 42 peer-reviewed publications and significant contributions to cancer research and biomedical nanotechnology, Salma is committed to advancing healthcare through innovative scientific solutions. Her exceptional academic performance and research efforts have earned her numerous awards and recognitions, marking her as a leader in her field. Currently, she serves as a Graduate Research Assistant while actively mentoring undergraduate and master’s students.

Education 🎓

Salma completed her Master of Science in Biomedical Sciences at Qatar University, graduating with a GPA of 3.65/4.00 in 2020. Her dissertation focused on the anticancer activity of guggulsterone in human leukemic cells. She earned her Bachelor of Science in Biomedical Sciences from the same institution in 2017, achieving a GPA of 3.10/4.00. Her undergraduate dissertation investigated the effects of iron chelation therapy on zebrafish models.

Experience 💼

Currently in her second year as a Ph.D. candidate and Graduate Research Assistant at Qatar University, Salma has extensive research experience. Previously, she worked as a Research Assistant at the Women’s Wellness and Research Center, Hamad Medical Corporation, and at the Biomedical Research Center of Qatar University. Salma also held a role as a Graduate Teaching Assistant, where she honed her teaching and mentoring skills, and served as a Lab Technologist at Qatar Biobank.

Research Interests 🔬

Salma’s research focuses on biomedical nanotechnology, particularly the synthesis and evaluation of novel 2D diphosphate nanocrystalline hydrogels for applications in skin infections and treatments. She is also deeply involved in cancer research, investigating molecular pathways and therapeutic strategies for chronic myeloid leukemia. Her commitment to public health is reflected in her studies on SARS-CoV-2 antibody responses and vaccine effectiveness.

Awards 🏆

Salma’s exceptional work has garnered several prestigious awards, including the Distinction in Academic Excellence from Qatar University in 2024 and the SIEED Innovation Pre-Incubation Program Award in both 2022 and 2023, where she received substantial funding for her research project. Additionally, she was recognized as the First Place Winner in the Graduate Research Award in Doha and was honored as a “Distinguished Graduate Student” by Qatar University in 2020, showcasing her dedication and impact in the field.

Publications 📚

Salma has contributed significantly to scientific literature, publishing in high-impact journals. Her key publications include:

  1. Younes, S., Nicolai, E., Pieri, M., Bernardini, S., Daas, H., Al-Sadeq, D., Younes, N., Shurrab, F., Nizamuddin, P., Humaira, F., Al-Dewik, N., Yassine, H., Abu-Raddad, L., Ismail, A. and Nasrallah, G. (2024). Follow-Up and Comparative Assessment of SARS-CoV-2 IgA, IgG, Neutralizing, and Total Antibody Responses After BNT162b2 or mRNA-1273 Heterologous Booster Vaccination. Influenza Other Respi Viruses, 18: e13290. DOI: 10.1111/irv.13290.
  2. Younes, S., Nicolai, E., Al-Sadeq, D.W., Younes, N., Al-Dewik, N., Abou-Saleh, H., et al. (2023). Follow-up and comparative assessment of IgG, IgA, and neutralizing antibody responses to SARS-CoV-2 between mRNA-vaccinated naïve and unvaccinated naturally infected individuals over 10 months. Journal of Infection and Public Health, 16(11): 1729-1735. DOI: 10.1016/j.jiph.2023.08.009.
  3. Younes, S., Zein, N., Abunasser, S., Kamareddine, L., Kirienko, N.V., Nasrallah, G.K. (2023). Editorial: Unconventional animal models in infectious disease research, volume II. Front Cell Infect Microbiol, 13: 1225129. DOI: 10.3389/fcimb.2023.1225129.
  4. Younes, S., Ismail, M.A., Al-Jurf, R., Ziyada, A., Nasrallah, G.K., Abdulrouf, P.V., et al. (2023). Management of chronic myeloid leukemia: current treatment options, challenges, and future strategies. Hematology, 28(1): 2196866. DOI: 10.1080/16078454.2023.2196866.
  5. Shurbaji, S., Al Tamimi, F., Al Ghwairi, M.M., El Chaar, D., Younes, S., Majdalawieh, A.F., et al. (2023). High-sensitive detection and quantitation of thyroid-stimulating hormone (TSH) from capillary/fingerstick and venepuncture whole-blood using fluorescence-based rapid lateral flow immunoassay (LFIA). Heliyon, 9(10): e20589. DOI: 10.1016/j.heliyon.2023.e20589.
  6. Al-Dewik, N., Samara, M., Younes, S., Al-Jurf, R., Nasrallah, G.K., Al-Obaidly, S., et al. (2023). Prevalence, predictors, and outcomes of major congenital anomalies: A population-based register study. Sci Rep, 13(1): 2198. DOI: 10.1038/s41598-023-27935-3.

Wei Meiqi | Exercise and health promotion | Best Researcher Award

Posted on by ScienceFather

Dr. Wei Meiqi | Exercise and health promotion | Best Researcher Award

PhD Candidate, Northeast Normal University, China

Meiqi Wei is a dedicated PhD candidate specializing in Exercise and Health Promotion at Northeast Normal University. Her academic journey began with a Bachelor’s degree in Sports Medicine from Shandong First Medical University, followed by a Master’s in Exercise and Human Science from Jilin University. She is actively engaged in research at the Chinese Center of Exercise Epidemiology, focusing on the integration of Big Data and AI with health promotion. Meiqi has published several influential papers and contributed significantly to interdisciplinary projects aimed at improving public health through data-driven insights.

Profile

Orcid

Education 🎓

Meiqi Wei’s educational background is marked by a strong foundation and advanced studies in sports and health sciences. She earned her B.S. in Sports Medicine from Shandong First Medical University. This was followed by an M.S. in Exercise and Human Science from Jilin University. Currently, she is pursuing her PhD in Exercise and Health Promotion at Northeast Normal University, where she continues to develop her expertise and contribute to her field.

Experience 💼

Throughout her academic career, Meiqi Wei has gained substantial experience in both research and practical applications of exercise and health sciences. She has been actively involved as a researcher in Computational Biology at the Chinese Center of Exercise Epidemiology. Her work spans several collaborative projects and consultancy roles, highlighting her ability to apply her research to real-world health challenges. Her experience is further solidified by her contributions to numerous high-impact scientific publications.

Research Interests 🔬

Meiqi Wei’s research interests lie at the intersection of Big Data, Artificial Intelligence, and Health Promotion. She focuses on leveraging computational biology methodologies to enhance epidemiological strategies. Her work aims to transform public health practices through data-driven insights, particularly in the areas of sarcopenia, physical fitness, and frailty in older adults. Her innovative approach seeks to improve the well-being of diverse populations by integrating advanced technological solutions into health promotion.

Awards 🏆

Meiqi Wei’s contributions to her field have been recognized through multiple nominations and accolades. She has authored three first-author SCI papers and published seven articles in indexed journals, three of which she led. Additionally, she holds two patents and has been involved in several high-profile collaborative projects. These achievements underscore her commitment to advancing health promotion through rigorous and impactful research.

Publications Top Notes📄

  1. Self-determined sequence exercise program for elderly with sarcopenia: A Randomized controlled trial with clinical assistance from explainable artificial intelligence
  2. Hybrid Exercise Program Enhances Physical Fitness and Reverses Frailty in Older Adults: Insights and Predictions from Machine Learning
  3. The Effectiveness of a Hybrid Exercise Program on the Physical Fitness of Frail Elderly
  4. Hybrid Exercise Program for Sarcopenia in Older Adults: The Effectiveness of Explainable Artificial Intelligence-Based Clinical Assistance in Assessing Skeletal Muscle Area